Mnk1 or Mnk2 inhibitors

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

Reexamination Certificate

active

08071607

ABSTRACT:
The present invention relates to the use of pyrazolopyrimidine compounds for the production of pharmaceutical compositions for the prophylaxis and/or treatment of diseases which can be influenced by the inhibition of the kinase activity of Mnk1 and/or Mnk2 (Mnk2aor Mnk2b) and/or variants thereof.

REFERENCES:
patent: 408945 (1966-03-01), None
patent: WO2004/037159 (2004-05-01), None
patent: WO2004/106340 (2004-12-01), None
Wolff et. al., “Burger's Medicinal Chemistry and Drug Discovery,” 5th Ed. Part 1, pp. 975-977 (1995).
http://www.medterms.com/script/main/art.asp?articlekey=12063, last accessed on Aug. 24, 2010.
Dorwald F. A. Side Reactions in Organic Synthesis, 2005, Wiley: VCH, Weinheim p. IX of Preface.
Banker, et. al., Modern Pharmaceuticals, p. 596.
Cheng, et al., “Potential Purine Antagonists, VI.”, Journal of Organic Chemistry, American Chemical Society, Easton, US, vol. 21, Nov. 1, 1956, pp. 1240-1256.
Young, et al., “Purine Derivatives as Competitive Inhibitors of Human Erythrocyte Membrane Phosphatidylinositol 4-Kinase”, Journal of Medicinal Chemistry, American Chemical Society. Washington, US, vol. 33, No. 8 Aug. 1, 1990, pp. 2073-2080.
Peat, et al., “Novel Pyrazolopyrimidine Derivatives as GSK-3 Inhibitors.” Bioorganic & Medicinal Chemistry Letters. May 3, 2004, vol. 14, No. 9, pp. 2121-2125.
Traxler et al., “Use of a Pharmacophore Model for the Design of EGF-R Tyrosine Kinase Inhibitors: 4-(Phenylamino)Pyrazolo3,4-Dpyrimidines”, Journal of Medicinal Chemistry, American Chemical Society, Washington, US, vol. 40, No. 22, 1997, pp. 3601-3616.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Mnk1 or Mnk2 inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Mnk1 or Mnk2 inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mnk1 or Mnk2 inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4293391

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.